Scarica l'app Stockscreener
1.11
5.93%
-0.07
Pre-mercato:
1.09
-0.02
-1.80%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Immunic Inc Borsa (IMUX) Ultime notizie
Immunic Stock Scheduled to Reverse Split on Monday, April 27th (NASDAQ:IMUX) - MarketBeat
D. Boral Capital Initiates Immunic(IMUX.US) With Hold Rating - Moomoo
IMUX Downgraded by D. Boral Capital -- Rating Changed to Hold - GuruFocus
This Parsons Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
D. Boral Capital cuts Immunic stock rating on reverse split concerns - Investing.com Australia
Immunic Sets 1-for-10 Reverse Stock Split Plan - TipRanks
Immunic shareholders approve 1-for-10 reverse stock split, effective April 27 - Investing.com India
Shareholders back Immunic (NASDAQ: IMUX) 1-for-10 reverse stock split move - Stock Titan
Immunic (IMUX) price target increased by 16.67% to 5.36 - MSN
If You Invested $1,000 in Immunic Inc (IMUX) - Stock Titan
Immunic (HAM:10VA) PB Ratio : (As of Apr. 11, 2026) - GuruFocus
Immunic, Inc. CEO Daniel Vitt Enters Retention Bonus Agreement Amid Search for New Chief Executive Officer - Minichart
Immunic (NASDAQ: IMUX) begins CEO search, grants $670k retention bonus - Stock Titan
Immunic Inc Stock Baskets | HAM:10VA - GuruFocus
Immunic (IMUX) Price Target Decreased by 17.29% to 6.41 - MSN
Q3 2024 Immunic Inc Earnings Call Transcript - GuruFocus
Immunic to Participate in Scientific and Medical Conferences in April - ChartMill
Immunic to present lead MS therapy at April conferences - Proactive financial news
Insider Sell: Can Immunic Inc ride the EV waveQuarterly Earnings Report & Short-Term High Return Ideas - baoquankhu1.vn
Immunic, Inc. (IMUX) stock price, news, quote and history - Yahoo Finance UK
Immunic COO highlights the importance of science-led innovation to mark World Health Day - Proactive financial news
IMUX SEC FilingsImmunic Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Immunic to offer up to 458.2 million shares of common stock registered for resale by selling stockholdersSEC filing - marketscreener.com
Immunic To Offer Up To 458.2 Million Shares Of Common Stock Registered For Resale By Selling StockholdersSEC Filing - TradingView — Track All Markets
According to the latest filing with the U.S. Securities and Exchange Commission (SEC), the biopharmaceutical company Immunic, Inc. has initiated an equity resale program. - Bitget
Immunic (NASDAQ: IMUX) registers 458.2M resale shares after $200M private placement - Stock Titan
Immunic Regains Nasdaq Compliance, Stabilizing Listing Status - The Globe and Mail
Immunic regains Nasdaq minimum bid price compliance By Investing.com - Investing.com South Africa
Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement - Sahm
Immunic, Inc. (IMUX) latest stock news and headlines - sg.finance.yahoo.com
Immunic Regains Nasdaq Compliance as IMUX Stock Maintains Minimum Bid Price Requirement - Minichart
Immunic regains Nasdaq minimum bid price compliance - Investing.com
Immunic Regains Nasdaq Minimum Bid Price Compliance After 20 Consecutive Business Days - TradingView
[8-K] IMMUNIC, INC. Reports Material Event - Stock Titan
Immunic AG / US4525EP1011 - AD HOC NEWS
Immunic appoints Jon Congleton to board of directors By Investing.com - Investing.com South Africa
IMUX: HC Wainwright & Co. Reiterates Buy Rating with $8 Target | - GuruFocus
Immunic (IMUX) director Jon Congleton files initial Form 3 - Stock Titan
Immunic Appoints Biopharma Leader Jon Congleton to Board, Advancing MS Therapy Toward Phase 3 Pivotal Readouts - Minichart
Small cap wrap: BioHarvest Sciences, American Resources, First Phosphate, Immunic... - Proactive financial news
Immunic Adds Veteran Biopharma Leader to Board - TipRanks
Immunic appoints biopharmaceutical executive Jon Congleton to board - Yahoo! Finance Canada
Immunic Appoints Jon Congleton To Board - citybiz
Immunic appoints Jon Congleton to board of directors - Investing.com
Biopharmaceutical company Immunic, Inc. recently announced the appointment of experienced industry executive Jon Congleton to its board of directors. - Bitget
Veteran biotech leader Jon Congleton joins Immunic (NASDAQ: IMUX) board - Stock Titan
Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton - PR Newswire
Smart Money: Is Immunic Inc stock a good dividend stock2026 Geopolitical Influence & Verified Short-Term Plans - baoquankhu1.vn
Growth Review: Is Immunic Inc undervalued by DCF analysisMarket Movement Recap & Fast Gaining Stock Reports - baoquankhu1.vn
Pharma News: Whats next for Immunic Inc stock2026 Action & Fast Gaining Stock Reports - baoquankhu1.vn
Immunic Inc Stock Warning Signs - GuruFocus
Guggenheim initiates coverage of Immunic (IMUX) with buy recommendation - MSN
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):